Tag Archives: Inhibit

Exploration of PRM-A as a Novel Glycan-Targeted Therapy to Inhibit SARS-CoV-2

HIV, Ebola, and most recently COVID-19 have had a huge impact on our societies around the world. All of these viruses are “enveloped viruses,” viruses that have an outer envelope that surrounds them, largely composed of host cells. This envelope increases the virus’ ability to hide from the host’s immune system and gain entry into […]